Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Targeting oncogenic drivers in lung cancer: Recent progress, current challenges and future opportunities.

Yoda S, Dagogo-Jack I, Hata AN.

Pharmacol Ther. 2018 Aug 16. pii: S0163-7258(18)30145-1. doi: 10.1016/j.pharmthera.2018.08.007. [Epub ahead of print] Review.

PMID:
30121320
2.

Prognostic impact of reducing myocardial ischemia identified using ECG-gated myocardial perfusion SPECT in Japanese patients with coronary artery disease: J-ACCESS 4 study.

Nanasato M, Matsumoto N, Nakajima K, Chikamori T, Moroi M, Takehana K, Momose M, Nishina H, Kasai T, Yoda S, Kiso K, Yamamoto H, Nishimura S, Yamashina A, Kusuoka H, Hirayama A, Nishimura T.

Int J Cardiol. 2018 Sep 15;267:202-207. doi: 10.1016/j.ijcard.2018.05.090. Epub 2018 May 24.

3.

Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer.

Yoda S, Lin JJ, Lawrence MS, Burke BJ, Friboulet L, Langenbucher A, Dardaei L, Prutisto-Chang K, Dagogo-Jack I, Timofeevski S, Hubbeling H, Gainor JF, Ferris LA, Riley AK, Kattermann KE, Timonina D, Heist RS, Iafrate AJ, Benes CH, Lennerz JK, Mino-Kenudson M, Engelman JA, Johnson TW, Hata AN, Shaw AT.

Cancer Discov. 2018 Jun;8(6):714-729. doi: 10.1158/2159-8290.CD-17-1256. Epub 2018 Apr 12.

PMID:
29650534
4.

SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.

Dardaei L, Wang HQ, Singh M, Fordjour P, Shaw KX, Yoda S, Kerr G, Yu K, Liang J, Cao Y, Chen Y, Lawrence MS, Langenbucher A, Gainor JF, Friboulet L, Dagogo-Jack I, Myers DT, Labrot E, Ruddy D, Parks M, Lee D, DiCecca RH, Moody S, Hao H, Mohseni M, LaMarche M, Williams J, Hoffmaster K, Caponigro G, Shaw AT, Hata AN, Benes CH, Li F, Engelman JA.

Nat Med. 2018 May;24(4):512-517. doi: 10.1038/nm.4497. Epub 2018 Mar 5.

PMID:
29505033
5.

Tracking the Evolution of Resistance to ALK Tyrosine Kinase Inhibitors through Longitudinal Analysis of Circulating Tumor DNA.

Dagogo-Jack I, Brannon AR, Ferris LA, Campbell CD, Lin JJ, Schultz KR, Ackil J, Stevens S, Dardaei L, Yoda S, Hubbeling H, Digumarthy SR, Riester M, Hata AN, Sequist LV, Lennes IT, Iafrate AJ, Heist RS, Azzoli CG, Farago AF, Engelman JA, Lennerz JK, Benes CH, Leary RJ, Shaw AT, Gainor JF.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.17.00160. Epub 2018 Jan 23.

6.

Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer.

Lin JJ, Zhu VW, Yoda S, Yeap BY, Schrock AB, Dagogo-Jack I, Jessop NA, Jiang GY, Le LP, Gowen K, Stephens PJ, Ross JS, Ali SM, Miller VA, Johnson ML, Lovly CM, Hata AN, Gainor JF, Iafrate AJ, Shaw AT, Ou SI.

J Clin Oncol. 2018 Apr 20;36(12):1199-1206. doi: 10.1200/JCO.2017.76.2294. Epub 2018 Jan 26.

PMID:
29373100
7.

Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non-Small-Cell Lung Cancer.

Gainor JF, Tseng D, Yoda S, Dagogo-Jack I, Friboulet L, Lin JJ, Hubbeling HG, Dardaei L, Farago AF, Schultz KR, Ferris LA, Piotrowska Z, Hardwick J, Huang D, Mino-Kenudson M, Iafrate AJ, Hata AN, Yeap BY, Shaw AT.

JCO Precis Oncol. 2017;2017. doi: 10.1200/PO.17.00063. Epub 2017 Aug 16.

8.

Effect of Aggressive lipid-lowering treatment with Rosuvastatin on vascular endoTHelium function: evaluation of vascular endothelium function (EARTH study).

Takayama T, Hiro T, Yoda S, Fukamachi D, Haruta H, Kogo T, Mineki T, Murata H, Oshima T, Hirayama A.

Heart Vessels. 2018 Jun;33(6):590-594. doi: 10.1007/s00380-017-1094-0. Epub 2017 Dec 5.

PMID:
29209775
9.

Translucent, hydrophobic, and mechanically tough aerogels constructed from trimethylsilylated chitosan nanofibers.

Takeshita S, Yoda S.

Nanoscale. 2017 Aug 31;9(34):12311-12315. doi: 10.1039/c7nr04051b.

PMID:
28825069
10.

Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction?

Asakura M, Kim J, Asanuma H, Hamasaki T, Tsukahara K, Higashino Y, Ishikawa T, Nakama Y, Koba S, Maruyama Y, Tsujimoto M, Himeno H, Ohkusa T, Fujino S, Shimizu M, Endo T, Yoda S, Muroya T, Murohara T, Ohte N, Suzuki H, Kohno T, Fukui K, Shiono T, Takase H, Uzui H, Nagai Y, Hashimoto Y, Ikeda S, Mizuno S, Tamita K, Fujita M, Satake K, Kinoshita Y, Nunohiro T, Sakagami S, Higaki J, Morii I, Sawada R, Hiasa Y, Shigemasa T, Nakahama M, Sata M, Doi O, Ueda T, Yamada T, Yamanouchi T, Yamaguchi H, Morita Y, Hayashi H, Kitakaze M; ABC investigators.

Cardiovasc Drugs Ther. 2017 Aug;31(4):401-411. doi: 10.1007/s10557-017-6740-3.

PMID:
28779371
11.

Correlation between early revascularization and major cardiac events demonstrated by ischemic myocardium in Japanese patients with stable coronary artery disease.

Yoda S, Hori Y, Hayase M, Mineki T, Hatta T, Suzuki Y, Matsumoto N, Hirayama A.

J Cardiol. 2018 Jan;71(1):44-51. doi: 10.1016/j.jjcc.2017.05.008. Epub 2017 Jul 18.

PMID:
28732592
12.

Toll ligand SpƤtzle3 controls melanization in the stripe pattern formation in caterpillars.

KonDo Y, Yoda S, Mizoguchi T, Ando T, Yamaguchi J, Yamamoto K, Banno Y, Fujiwara H.

Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8336-8341. doi: 10.1073/pnas.1707896114. Epub 2017 Jul 17. Erratum in: Proc Natl Acad Sci U S A. 2017 Sep 5;:.

13.

Aldehyde Approach to Hydrophobic Modification of Chitosan Aerogels.

Takeshita S, Konishi A, Takebayashi Y, Yoda S, Otake K.

Biomacromolecules. 2017 Jul 10;18(7):2172-2178. doi: 10.1021/acs.biomac.7b00562. Epub 2017 Jun 28.

PMID:
28657715
14.

Egg white hydrolysate inhibits oxidation in mayonnaise and a model system.

Kobayashi H, Sasahara R, Yoda S, Kotake-Nara E.

Biosci Biotechnol Biochem. 2017 Jun;81(6):1206-1215. doi: 10.1080/09168451.2017.1290519. Epub 2017 Feb 16.

PMID:
28485214
15.

Erlotinib as second- or third-line treatment in elderly patients with advanced non-small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001).

Miyawaki M, Naoki K, Yoda S, Nakayama S, Satomi R, Sato T, Ikemura S, Ohgino K, Ishioka K, Arai D, Namkoong H, Otsuka K, Miyazaki M, Tani T, Kuroda A, Nishino M, Yasuda H, Kawada I, Koh H, Nakamura M, Terashima T, Sakamaki F, Sayama K, Betsuyaku T, Soejima K.

Mol Clin Oncol. 2017 Mar;6(3):409-414. doi: 10.3892/mco.2017.1154. Epub 2017 Feb 6.

16.

Intra-arterial Contrasted Cone-beam Computed Tomography Assessment of Vessels Distal from Occluded Site in Acute Ischemic Stroke with Major Vessel Occlusion.

Amano T, Sato M, Matsumaru Y, Sakuma H, Yoda S, Hamada Y.

Neurol Med Chir (Tokyo). 2017 Jun 15;57(6):292-298. doi: 10.2176/nmc.tn.2016-0291. Epub 2017 Apr 26.

17.

Prognostic study of cardiac events in Japanese patients with chronic kidney disease using ECG-gated myocardial Perfusion imaging: Final 3-year report of the J-ACCESS 3 study.

Nakamura S, Kawano Y, Nakajima K, Hase H, Joki N, Hatta T, Nishimura S, Moroi M, Nakagawa S, Kasai T, Kusuoka H, Takeishi Y, Momose M, Takehana K, Nanasato M, Yoda S, Nishina H, Matsumoto N, Nishimura T.

J Nucl Cardiol. 2017 Apr 24. doi: 10.1007/s12350-017-0880-5. [Epub ahead of print]

PMID:
28439760
18.

High-voltage zones within the pulmonary vein antra: Major determinants of acute pulmonary vein reconnections after atrial fibrillation ablation.

Nagashima K, Watanabe I, Okumura Y, Iso K, Takahashi K, Watanabe R, Arai M, Kurokawa S, Nakai T, Ohkubo K, Yoda S, Hirayama A.

J Interv Card Electrophysiol. 2017 Aug;49(2):137-145. doi: 10.1007/s10840-017-0252-8. Epub 2017 Apr 21.

PMID:
28432503
19.

Ventricular Tachycardia as a Complication of Ledipasvir and Sofosbuvir Treatment for HCV Infection.

Nirei K, Nakamura H, Matsuoka S, Yamana Y, Yoda S, Hirayama A, Moriyama M.

Intern Med. 2017;56(7):787-790. doi: 10.2169/internalmedicine.56.7948. Epub 2017 Apr 1.

20.

Depiction of the discrepancy between fatty-acid metabolism and myocardial perfusion in takotsubo cardiomyopathy using dedicated cardiac semiconductor gamma camera.

Iida K, Matsumoto N, Makita A, Suzuki Y, Yoda S, Hirayama A.

Int J Cardiol. 2016 Nov 15;223:161-162. doi: 10.1016/j.ijcard.2016.08.165. Epub 2016 Aug 9. No abstract available.

PMID:
27537748
21.

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.

Gainor JF, Dardaei L, Yoda S, Friboulet L, Leshchiner I, Katayama R, Dagogo-Jack I, Gadgeel S, Schultz K, Singh M, Chin E, Parks M, Lee D, DiCecca RH, Lockerman E, Huynh T, Logan J, Ritterhouse LL, Le LP, Muniappan A, Digumarthy S, Channick C, Keyes C, Getz G, Dias-Santagata D, Heist RS, Lennerz J, Sequist LV, Benes CH, Iafrate AJ, Mino-Kenudson M, Engelman JA, Shaw AT.

Cancer Discov. 2016 Oct;6(10):1118-1133. Epub 2016 Jul 18.

22.

Prognostic Value of Major Cardiac Event Risk Score Estimated With Gated Myocardial Perfusion Imaging in Japanese Patients With Coronary Artery Disease.

Yoda S, Nakanishi K, Tano A, Hori Y, Hayase M, Mineki T, Suzuki Y, Matsumoto N, Hirayama A.

Int Heart J. 2016 Jul 27;57(4):408-16. doi: 10.1536/ihj.15-428. Epub 2016 Jun 29.

23.

Development of Human-Like Advanced Coronary Plaques in Low-Density Lipoprotein Receptor Knockout Pigs and Justification for Statin Treatment Before Formation of Atherosclerotic Plaques.

Li Y, Fuchimoto D, Sudo M, Haruta H, Lin QF, Takayama T, Morita S, Nochi T, Suzuki S, Sembon S, Nakai M, Kojima M, Iwamoto M, Hashimoto M, Yoda S, Kunimoto S, Hiro T, Matsumoto T, Mitsumata M, Sugitani M, Saito S, Hirayama A, Onishi A.

J Am Heart Assoc. 2016 Apr 18;5(4):e002779. doi: 10.1161/JAHA.115.002779.

24.

Intraluminal superior vena cava metastasis from adenosquamous carcinoma of the duodenum: A case report.

Takayoshi K, Ariyama H, Tamura S, Yoda S, Arita T, Yamaguchi T, Ozono K, Yamamoto H, Inadomi K, Kumagai H, Tanaka M, Okumura Y, Sagara K, Nio K, Nakano M, Arita S, Kusaba H, Odashiro K, Oda Y, Akashi K, Baba E.

Oncol Lett. 2016 Jan;11(1):605-609. Epub 2015 Nov 18.

25.

Clinical Feasibility of Simultaneous Acquisition Rest (99m)Tc/Stress (201)Tl Dual-Isotope Myocardial Perfusion Single-Photon Emission Computed Tomography With Semiconductor Camera.

Makita A, Matsumoto N, Suzuki Y, Hori Y, Kuronuma K, Yoda S, Kasama S, Iguchi N, Suzuki Y, Hirayama A.

Circ J. 2016;80(3):689-95. doi: 10.1253/circj.CJ-15-1077. Epub 2016 Jan 18.

26.

Improvements in Augmentation Index and Urinary Albumin Excretion With Benidipine in Hypertensive Patients With Chronic Kidney Disease.

Takayama T, Yoda S, Yajima Y, Kasamaki Y, Kunimoto S, Kanai T, Hirayama A.

Int Heart J. 2016;57(1):53-60. doi: 10.1536/ihj.15-208. Epub 2016 Jan 6.

27.

Aerodynamic levitator for large-sized glassy material production.

Yoda S, Cho WS, Imai R.

Rev Sci Instrum. 2015 Sep;86(9):093906. doi: 10.1063/1.4930008.

PMID:
26429456
28.

Endoscopic Transseptal Approach to Frontal Sinus Disease.

Nishiike S, Yoda S, Shikina T, Murata J.

Indian J Otolaryngol Head Neck Surg. 2015 Sep;67(3):287-91. doi: 10.1007/s12070-015-0879-7. Epub 2015 Jun 29.

29.

[Estimation of Maximum Entrance Skin Dose during Cerebral Angiography].

Kawauchi S, Moritake T, Hayakawa M, Hamada Y, Sakuma H, Yoda S, Satoh M, Sun L, Koguchi Y, Akahane K, Chida K, Matsumaru Y.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2015 Sep;71(9):746-57. doi: 10.6009/jjrt.2015_JSRT_71.9.746. Japanese.

30.

Major cardiac event risk scores estimated with gated myocardial perfusion imaging in Japanese patients with coronary artery disease.

Yoda S, Nakanishi K, Tano A, Hori Y, Suzuki Y, Matsumoto N, Hirayama A.

J Cardiol. 2016 Jan;67(1):64-70. doi: 10.1016/j.jjcc.2015.04.008. Epub 2015 May 14.

31.

Unexpected massive hemorrhage following the removal of a pleural drainage tube.

Seki M, Yoda S.

Intern Med. 2015;54(8):953-4. doi: 10.2169/internalmedicine.54.3719. Epub 2015 Apr 15.

32.

Significance of worsening renal function and nuclear cardiology for predicting cardiac death in patients with known or suspected coronary artery disease.

Yoda S, Nakanishi K, Tano A, Hori Y, Suzuki Y, Matsumoto N, Hirayama A.

J Cardiol. 2015 Nov;66(5):423-9. doi: 10.1016/j.jjcc.2015.01.003. Epub 2015 Feb 18.

33.

A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer.

Ikemura S, Naoki K, Yasuda H, Kawada I, Yoda S, Terai H, Sato T, Ishioka K, Arai D, Ohgino K, Kamata H, Miyata J, Kabata H, Betsuyaku T, Soejima K.

Jpn J Clin Oncol. 2015 Apr;45(4):356-61. doi: 10.1093/jjco/hyu226. Epub 2015 Jan 22.

PMID:
25612761
34.

A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer.

Soejima K, Naoki K, Ishioka K, Nakamura M, Nakatani M, Kawada I, Watanabe H, Nakachi I, Yasuda H, Satomi R, Nakayama S, Yoda S, Ikemura S, Terai H, Sato T, Ohgino K, Arai D, Tani T, Kuroda A, Nishino M, Betsuyaku T.

Cancer Chemother Pharmacol. 2015 Mar;75(3):513-9. doi: 10.1007/s00280-014-2673-8. Epub 2015 Jan 7.

PMID:
25563719
35.

FOXD1 expression is associated with poor prognosis in non-small cell lung cancer.

Nakayama S, Soejima K, Yasuda H, Yoda S, Satomi R, Ikemura S, Terai H, Sato T, Yamaguchi N, Hamamoto J, Arai D, Ishioka K, Ohgino K, Naoki K, Betsuyaku T.

Anticancer Res. 2015 Jan;35(1):261-8.

PMID:
25550559
36.

Methylation-induced downregulation of TFPI-2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non-small-cell lung carcinoma.

Hamamoto J, Soejima K, Naoki K, Yasuda H, Hayashi Y, Yoda S, Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Arai D, Ishioka K, Ohgino K, Betsuyaku T.

Cancer Sci. 2015 Jan;106(1):34-42. doi: 10.1111/cas.12569. Epub 2014 Dec 8.

37.

The transcription factor Apontic-like controls diverse colouration pattern in caterpillars.

Yoda S, Yamaguchi J, Mita K, Yamamoto K, Banno Y, Ando T, Daimon T, Fujiwara H.

Nat Commun. 2014 Sep 18;5:4936. doi: 10.1038/ncomms5936.

PMID:
25233442
38.

Myocardial ischemic reduction evidenced by gated myocardial perfusion imaging after treatment results in good prognosis in patients with coronary artery disease.

Hori Y, Yoda S, Nakanishi K, Tano A, Suzuki Y, Matsumoto N, Hirayama A.

J Cardiol. 2015 Apr;65(4):278-84. doi: 10.1016/j.jjcc.2014.06.015. Epub 2014 Jul 28.

39.

The truncation artefact in patients with a high body mass index on myocardial perfusion SPECT.

Matsumoto N, Suzuki Y, Yoda S, Hirayama A.

BMJ Case Rep. 2014 Jul 15;2014. pii: bcr2014205407. doi: 10.1136/bcr-2014-205407. No abstract available.

40.

Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.

Yoda S, Soejima K, Hamamoto J, Yasuda H, Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Naoki K, Betsuyaku T.

Lung Cancer. 2014 Sep;85(3):366-72. doi: 10.1016/j.lungcan.2014.06.009. Epub 2014 Jun 21.

PMID:
25001509
41.

Myocardial perfusion imaging for predicting cardiac events in Japanese patients with advanced chronic kidney disease: 1-year interim report of the J-ACCESS 3 investigation.

Joki N, Hase H, Kawano Y, Nakamura S, Nakajima K, Hatta T, Nishimura S, Moroi M, Nakagawa S, Kasai T, Kusuoka H, Takeishi Y, Momose M, Takehana K, Nanasato M, Yoda S, Nishina H, Matsumoto N, Nishimura T.

Eur J Nucl Med Mol Imaging. 2014 Sep;41(9):1701-9. doi: 10.1007/s00259-014-2781-z. Epub 2014 May 15.

PMID:
24827603
42.

Reverse redistribution pattern in rest Tl-201 and stress Tc-99m SPECT in patients undergoing coronary interventions.

Matsumoto N, Yoda S, Nagao K, Hirayama A.

BMJ Case Rep. 2014 Apr 17;2014. pii: bcr2014204325. doi: 10.1136/bcr-2014-204325. No abstract available.

43.
44.

Validation of automated quantification of nuclear cardiology in Japanese patients using total perfusion deficits: Comparison with visual assessment.

Yoda S, Nakanishi K, Tano A, Hori Y, Suzuki Y, Matsumoto N, Hirayama A.

J Cardiol. 2014 May;63(5):350-7. doi: 10.1016/j.jjcc.2013.10.004. Epub 2013 Nov 18.

45.

Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer.

Ohgino K, Soejima K, Yasuda H, Hayashi Y, Hamamoto J, Naoki K, Arai D, Ishioka K, Sato T, Terai H, Ikemura S, Yoda S, Tani T, Kuroda A, Betsuyaku T.

Lung Cancer. 2014 Jan;83(1):90-6. doi: 10.1016/j.lungcan.2013.10.016. Epub 2013 Oct 30.

PMID:
24239165
46.

Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.

Hamamoto J, Soejima K, Yoda S, Naoki K, Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Yasuda H, Hayashi Y, Sakamoto M, Takebayashi T, Betsuyaku T.

Mol Med Rep. 2013 Aug;8(2):456-62. doi: 10.3892/mmr.2013.1517. Epub 2013 Jun 11.

PMID:
23759980
47.

Diagnostic value of automated quantification of nuclear cardiology in Japanese patients with single vessel coronary artery disease: comparison between Japanese and American normal databases.

Yoda S, Nakanishi K, Tano A, Hori Y, Suzuki Y, Matsumoto N, Hirayama A.

J Cardiol. 2013 Oct;62(4):224-9. doi: 10.1016/j.jjcc.2013.04.001. Epub 2013 May 31.

48.

Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC.

Terai H, Soejima K, Yasuda H, Nakayama S, Hamamoto J, Arai D, Ishioka K, Ohgino K, Ikemura S, Sato T, Yoda S, Satomi R, Naoki K, Betsuyaku T.

Mol Cancer Res. 2013 Jul;11(7):759-67. doi: 10.1158/1541-7786.MCR-12-0652. Epub 2013 Mar 27.

49.

Risk stratification of cardiovascular events in patients at all stages of chronic kidney disease using myocardial perfusion SPECT.

Yoda S, Nakanishi K, Tano A, Kasamaki Y, Kunimoto S, Matsumoto N, Sato Y, Hirayama A.

J Cardiol. 2012 Nov;60(5):377-82. doi: 10.1016/j.jjcc.2012.06.011. Epub 2012 Aug 11.

50.

Platelet aggregometry in the presence of PGE(1) provides a reliable method for cilostazol monitoring.

Satoh K, Fukasawa I, Kanemaru K, Yoda S, Kimura Y, Inoue O, Ohta M, Kinouchi H, Ozaki Y.

Thromb Res. 2012 Oct;130(4):616-21. doi: 10.1016/j.thromres.2012.05.030. Epub 2012 Jun 22.

PMID:
22728022

Supplemental Content

Support Center